Preface
Report of ITMIG 2015 Meeting
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:S177-S179
.
(10 December 2015)
Oral 1—Abstract Session 1: Molecular Biology and Chemotherapy
Oral 1.01. Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:101
.
(10 December 2015)
Oral 1.02. Sunitinib in patients with advanced thymic epithelial tumors (TET)
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:102
.
(10 December 2015)
Oral 1.03. Frequent PD-L1 expression in thymic squamous cell carcinoma of Chinese patients
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:103
.
(10 December 2015)
Oral 1.04. MicroRNA networks: novel key regulators in thymic epithelial tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:104
.
(10 December 2015)
Oral 2—Abstract Session 2: Treatment and Novel Approaches
Oral 2.01. Proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:201
.
(10 December 2015)
Oral 2.02. The role of postoperative radiotherapy for stage I/II/III thymic tumor—results of chart database
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:202
.
(10 December 2015)
Oral 2.03. S-1 salvage treatment for chemorefractory stage IV thymic carcinoma: a report of 19 cases
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:203
.
(10 December 2015)
Oral 2.04. Expression and significance of c-kit and EMT molecules in thymic epithelial tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:204
.
(10 December 2015)
Oral 3—Abstract Session 3: Regional Trends
Oral 3.01. Malignant thymoma incidence in a Chinese population
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:301
.
(10 December 2015)
Oral 3.02. Postoperative survival for patients with thymoma complicating myasthenia gravis—chart experience
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:302
.
(10 December 2015)
Oral 3.03. Increasing number of thymectomies performed in the United States
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:303
.
(10 December 2015)
Oral 3.04. The extent of lymph node dissection in thymic malignancies
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:304
.
(10 December 2015)
Oral 4—Abstract Session 4: Patient Evaluation
Oral 4.01. Comparison between computed tomography and magnetic resonance imaging in preoperative evaluation of thymic epithelial tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:401
.
(10 December 2015)
Oral 4.02. Dynamic contrast-enhanced MR imaging in risk stratification of thymic epithelial tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:402
.
(10 December 2015)
Oral 4.03. Needs assessment and design of the first thymic malignancy and myasthenia gravis program
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:403
.
(10 December 2015)
Oral 4.04. Emergency presentation of mediastinal tumors: a clinicopathological study
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:404
.
(10 December 2015)
Poster Session
P01. Long-term survival after surgical treatment of thymic carcinoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P01
.
(10 December 2015)
P02. Comparison a novel 3-hole surgery with VATS for myasthenia gravis: a retrospective study
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P02
.
(10 December 2015)
P03. Thymic neuroendocrine tumors: analysis of factors affecting survival
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P03
.
(10 December 2015)
P04. Elevated serum lactate dehydrogenase level predicts both poor overall survival and short recurrence-free survival after resection of thymic carcinoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P04
.
(10 December 2015)
P05. Low-dose radiotherapy for the treatment of pleural recurrence of thymic carcinoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P05
.
(10 December 2015)
P06. A new surgical method for anterior mediastinum tumors: a 3-hole approach
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P06
.
(10 December 2015)
P07. Effectiveness of cytotoxic agent etoposide after target therapy in advanced thymic tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P07
.
(10 December 2015)
P08. Somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P08
.
(10 December 2015)
P09. Diagnosis of advanced thymic epithelial tumors in patients previously affected by thymic hyperplasia
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P09
.
(10 December 2015)
P10. Is the OctreoScan score a predictive factor of response to somatostatin analogs treatment?
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P10
.
(10 December 2015)
P11. 18FDG-PET/CT for early prediction of response to first line platinum chemotherapy in advanced thymic epithelial tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P11
.
(10 December 2015)
P12. Somatostatin analogs as maintenance therapy in heavily pretreated thymic epithelial tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P12
.
(10 December 2015)
P13. Establishment and charactrization of a novel human thymoma cell line
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P13
.
(10 December 2015)
P14. Feasibility of “subxiphoid and subcostal” approach in video-assisted thoracoscopic thymectomy for patients with myasthenia gravis
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P14
.
(10 December 2015)
P15. The expression of Tc17 cells in thymoma accompany with autoimmune diseases or autoimmune disorders
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P15
.
(10 December 2015)
P16. The impact of thymoma cell apoptosis after down Wnt4 gene
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P16
.
(10 December 2015)
P17. Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P17
.
(10 December 2015)
P18. Thoracoscopic complete thymectomy for thymoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P18
.
(10 December 2015)
P19. Combined transcervical and bilateral-thoracoscopic extended thymectomy for thymoma with MG
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P19
.
(10 December 2015)
P20. Expression and clinical significance of autoimmune regulator in thymomas with autoimmune disease
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P20
.
(10 December 2015)
P21. To explore the value of Qiangji Jianli method for the MG patients underwent extended thymectomy
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P21
.
(10 December 2015)
P22. The clinical value of biomarker in the thymic tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P22
.
(10 December 2015)
P23. Tumor volume of thymic epithelial tumors based on who histological classification
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P23
.
(10 December 2015)
P24. The predictive role of the WHO histological classification in the treatment of advanced thymoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P24
.
(10 December 2015)
P25. VATS combined with a subxiphoid incision: a novel approach for large thymoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P25
.
(10 December 2015)
P26. Analysis of immune makers and clinical significance in thymomas with autoimmune disease in thymoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P26
.
(10 December 2015)
P27. Induction but not extrapleural pneumonectomy may be important in the treatment for stage IVa thymoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P27
.
(10 December 2015)
P28. Pridictors and management for the primary IVa thymoma
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P28
.
(10 December 2015)
P29. Evolution of minimally invasive surgery in the management of thymic masses at a single institution
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P29
.
(10 December 2015)
P30. A case of anterior mediastinitis and bilateral multiple lung abscesses occurring after TsTET
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P30
.
(10 December 2015)
P31. Salvage surgery for PMGCT: beneficial for persistent positive-marker patients?
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P31
.
(10 December 2015)
P32. Comparing radiotherapy with free breathing and deep inspiration breath hold for thymic cancers
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P32
.
(10 December 2015)
P33. Predictive factors of extended thymectomy for myasthenia gravis
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P33
.
(10 December 2015)
P34. The clinical analysis of subxiphoid approach of VATS anterior mediastinal mass extended resection
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P34
.
(10 December 2015)
P35. Study on the loss of heterozygosity of microsatellite allele in thymic epithelial tumors
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P35
.
(10 December 2015)
P36. Thoracoscopic resection of bulky thymoma using artificial pneumothorax
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P36
.
(10 December 2015)
P37. Locally advanced thymoma-robotic approach
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P37
.
(10 December 2015)
P38. Reoperation for recurrent thymoma: a single-center experience from Nanchang
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P38
.
(10 December 2015)
P39. Effects of TNIP1/TNFAIP3 expression: implications for myasthenia gravis
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P39
.
(10 December 2015)
P40. Does IL8 (CXCL8) have a role in thymoma progression and as a marker for relapse?
Journal of Thoracic Disease
2015;
7
(Suppl 3)
:P40
.
(10 December 2015)
Disclosure:
The supplement “Abstract Book for the 6th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2015)” was commissioned by the editorial office, Journal of Thoracic Disease without any sponsorship or funding. Frank Detterbeck served as the unpaid Guest Editor for the supplement.
